ASX - By Stock
|
AT1 |
Re:
Ann: Investor Presentation
|
|
FinFree101
|
47 |
20K |
8 |
25/02/22 |
25/02/22 |
ASX - By Stock
|
47
|
20K
|
8
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Atomo H1 FY22 Results Investor Briefing
|
|
FinFree101
|
13 |
5.4K |
3 |
21/02/22 |
21/02/22 |
ASX - By Stock
|
13
|
5.4K
|
3
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
FinFree101
|
1.8K |
584K |
6 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
1.8K
|
584K
|
6
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
FinFree101
|
1.8K |
584K |
1 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
1.8K
|
584K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Atomo receives approval for its COVID-19 antigen test in NZ
|
|
FinFree101
|
14 |
7.8K |
2 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
14
|
7.8K
|
2
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Victorian Government Intent for Lumos Manufacturing Hub
|
|
FinFree101
|
114 |
39K |
6 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
114
|
39K
|
6
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
FinFree101
|
1.8K |
584K |
9 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
1.8K
|
584K
|
9
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
FinFree101
|
3 |
1.2K |
1 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
3
|
1.2K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
FinFree101
|
2.4K |
764K |
6 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
2.4K
|
764K
|
6
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
FinFree101
|
2.4K |
764K |
7 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
2.4K
|
764K
|
7
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
FinFree101
|
1.8K |
584K |
4 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
1.8K
|
584K
|
4
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
FinFree101
|
1.8K |
584K |
7 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
1.8K
|
584K
|
7
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
FinFree101
|
1.8K |
584K |
4 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
1.8K
|
584K
|
4
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
FinFree101
|
2.4K |
764K |
10 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
2.4K
|
764K
|
10
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
FinFree101
|
2.4K |
764K |
7 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
2.4K
|
764K
|
7
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
FinFree101
|
2.4K |
764K |
22 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
2.4K
|
764K
|
22
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
FinFree101
|
1.8K |
584K |
4 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
1.8K
|
584K
|
4
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Atomo receives approval for its COVID-19 antigen test in NZ
|
|
FinFree101
|
14 |
7.8K |
17 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
14
|
7.8K
|
17
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Atomo receives approval for its COVID-19 antigen test in NZ
|
|
FinFree101
|
14 |
7.8K |
17 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
14
|
7.8K
|
17
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Quarterly Activity Report - 31 December 2021
|
|
FinFree101
|
9 |
3.4K |
4 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
9
|
3.4K
|
4
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Investor Briefing - Q2 FY22 Results
|
|
FinFree101
|
5 |
2.5K |
6 |
26/01/22 |
26/01/22 |
ASX - By Stock
|
5
|
2.5K
|
6
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
FinFree101
|
2.4K |
764K |
10 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
2.4K
|
764K
|
10
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
FinFree101
|
2.4K |
764K |
3 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
2.4K
|
764K
|
3
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
FinFree101
|
2.4K |
764K |
4 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
2.4K
|
764K
|
4
|
|
ASX - By Stock
|
AT1 |
Re:
CHART
|
|
FinFree101
|
9 |
3.0K |
1 |
27/11/21 |
27/11/21 |
ASX - By Stock
|
9
|
3.0K
|
1
|
|
ASX - By Stock
|
LDX |
Re:
FA/General Discussion
|
|
FinFree101
|
21 |
5.7K |
2 |
26/11/21 |
26/11/21 |
ASX - By Stock
|
21
|
5.7K
|
2
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
FinFree101
|
2.4K |
764K |
7 |
26/11/21 |
26/11/21 |
ASX - By Stock
|
2.4K
|
764K
|
7
|
|
ASX - By Stock
|
LDX |
Re:
FA/General Discussion
|
|
FinFree101
|
21 |
5.7K |
1 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
21
|
5.7K
|
1
|
|
ASX - By Stock
|
LDX |
Re:
FA/General Discussion
|
|
FinFree101
|
21 |
5.7K |
3 |
22/11/21 |
22/11/21 |
ASX - By Stock
|
21
|
5.7K
|
3
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
FinFree101
|
2.4K |
764K |
6 |
22/11/21 |
22/11/21 |
ASX - By Stock
|
2.4K
|
764K
|
6
|
|
ASX - By Stock
|
LDX |
Re:
FA/General Discussion
|
|
FinFree101
|
21 |
5.7K |
2 |
22/11/21 |
22/11/21 |
ASX - By Stock
|
21
|
5.7K
|
2
|
|
ASX - By Stock
|
AT1 |
Re:
Why I think I should not hold AT1 anymore
|
|
FinFree101
|
50 |
25K |
14 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
50
|
25K
|
14
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
FinFree101
|
1.8K |
584K |
2 |
01/11/21 |
01/11/21 |
ASX - By Stock
|
1.8K
|
584K
|
2
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
FinFree101
|
1.8K |
584K |
11 |
01/11/21 |
01/11/21 |
ASX - By Stock
|
1.8K
|
584K
|
11
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
FinFree101
|
2.4K |
764K |
8 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
2.4K
|
764K
|
8
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
FinFree101
|
1.8K |
584K |
13 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
1.8K
|
584K
|
13
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
FinFree101
|
2.4K |
764K |
25 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
2.4K
|
764K
|
25
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
FinFree101
|
2.4K |
764K |
8 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
2.4K
|
764K
|
8
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
FinFree101
|
1.8K |
584K |
3 |
27/10/21 |
27/10/21 |
ASX - By Stock
|
1.8K
|
584K
|
3
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
FinFree101
|
1.8K |
584K |
2 |
27/10/21 |
27/10/21 |
ASX - By Stock
|
1.8K
|
584K
|
2
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
FinFree101
|
1.8K |
584K |
6 |
27/10/21 |
27/10/21 |
ASX - By Stock
|
1.8K
|
584K
|
6
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
FinFree101
|
2.4K |
764K |
6 |
27/10/21 |
27/10/21 |
ASX - By Stock
|
2.4K
|
764K
|
6
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
FinFree101
|
1.8K |
584K |
5 |
26/10/21 |
26/10/21 |
ASX - By Stock
|
1.8K
|
584K
|
5
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Quarterly Activity Report - 30 September 2021
|
|
FinFree101
|
9 |
3.9K |
3 |
26/10/21 |
26/10/21 |
ASX - By Stock
|
9
|
3.9K
|
3
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: HIV Self-Test - improved supply & advertising conditions
|
|
FinFree101
|
9 |
3.0K |
9 |
26/10/21 |
26/10/21 |
ASX - By Stock
|
9
|
3.0K
|
9
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Quarterly Activity Report - 30 September 2021
|
|
FinFree101
|
9 |
3.9K |
2 |
25/10/21 |
25/10/21 |
ASX - By Stock
|
9
|
3.9K
|
2
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Appendix 4C - 30 September 2021
|
|
FinFree101
|
3 |
1.5K |
2 |
25/10/21 |
25/10/21 |
ASX - By Stock
|
3
|
1.5K
|
2
|
|
ASX - By Stock
|
LDX |
Re:
FA/General Discussion
|
|
FinFree101
|
21 |
5.7K |
2 |
25/10/21 |
25/10/21 |
ASX - By Stock
|
21
|
5.7K
|
2
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Update on Economic Evaluation of FebriDx
|
|
FinFree101
|
8 |
2.3K |
3 |
08/10/21 |
08/10/21 |
ASX - By Stock
|
8
|
2.3K
|
3
|
|
Charts
|
AT1 |
Re:
AT1 chart
|
|
FinFree101
|
389 |
152K |
1 |
07/10/21 |
07/10/21 |
Charts
|
389
|
152K
|
1
|
|